Hereditary Hypotrichosis Simplex
Hereditary hypotrichosis simplex (HHS) is a group of rare inherited disorders in which scalp and body hair is progressively lost, starting in childhood.
Unlike the ectodermal dysplasias, HHS is non-syndromic: only the hair follicles are affected, while teeth, nails, sweat glands, vision and intellectual development are entirely normal.
At the molecular level, HHS reflects weakened signals for follicle differentiation and renewal of the hair cycle:
- Autosomal Dominant Form (AD-HHS): APCDD1 or RPL21 Mutations
- The APCDD1 gene (chromosome 18p11.22) encodes a membrane protein that inhibits Wnt/beta-catenin signaling.
- Dominant variants cause APCDD1 to accumulate or malfunction, shutting down the Wnt signaling that hair follicle stem cells need to survive. As a result, follicles gradually shrink (follicular miniaturization) and stop producing mature hair shafts.
- Autosomal Recessive Form (AR-HHS): LPAR6, LIPH or DSG4 Mutations
- Recessive mutations in LPAR6 (lysophosphatidic acid receptor 6) or LIPH (lipase H) disrupt the lipid signaling that drives proliferation of hair matrix cells.
- Mutations in DSG4 (desmoglein 4) weaken the desmosome connections between hair cortex cells and the inner root sheath, so hairs break easily and the follicle eventually disappears.
HHS is often diagnosed late or confused with diffuse alopecia areata in children. At Haute-Derma, the key clues we look for are symmetric, progressive hair loss with no scalp inflammation, onset in childhood, and (in the dominant form) relatives with the same problem.
Clinical Features and Trichoscopy Findings
HHS runs a long course, with hair density falling gradually over time:
- How It Presents at Different Ages:
- Newborns: Babies are usually born with normal or only slightly sparse hair.
- Early childhood (2–6 years): Hair begins to thin across the whole scalp. New hairs grow in finer, shorter, dry and dull, and cannot grow longer than a few centimeters.
- Puberty and adulthood: Ongoing loss leaves the scalp almost completely bald. Eyebrows, eyelashes, underarm, pubic and body hair also become sparse or disappear entirely. The scalp is smooth and soft, with no scarring or atrophy.
- Trichoscopy and Histopathology:
- Follicular miniaturization: Scalp dermoscopy shows marked variation in hair shaft diameter, with fine vellus hairs far outnumbering terminal hairs.
- Fewer hairs per follicular opening: Each follicular unit produces only a single hair, or the opening is empty.
- Yellow dots: Empty follicular openings filled with sebum, without any surrounding inflammation.
Comparison of Congenital Inherited Hair-Thinning Disorders
| Hereditary Hypotrichosis Simplex (HHS) | Marie Unna Hereditary Hypotrichosis (MUHH) | Congenital Atrichia |
|---|---|---|
| Wnt pathway defect (APCDD1) or LPAR6/LIPH. | Mutation in the U2HR region (increased HR). | Loss-of-function mutation in the HR gene. |
| No systemic features. | No systemic features. | Sometimes with papular lesions. |
| Fine hair, thinning diffusely. | Coarse, wiry hair. | All hair shed after birth and never regrows. |
| Sparse or absent eyebrows/eyelashes. | Mildly sparse eyebrows/eyelashes. | Complete loss of body hair. |
| Progressive, permanent loss. | Progressive balding from puberty. | Lifelong, permanent baldness. |
Management and Clinical Care at Haute-Derma
There is currently no gene therapy that can reverse the damage in HHS. Care focuses on slowing follicle miniaturization and supporting appearance:
Supportive Treatment to Preserve Follicles
- Topical minoxidil (2%–5%): Started early, minoxidil may improve blood flow to the follicles and prolong the anagen phase in follicles that have not fully miniaturized, helping hold on to thin hair for as long as possible.
- Low-level laser therapy (LLLT): Stimulates mitochondria in hair matrix cells to produce ATP, which may help slow miniaturization.
Genetic Counseling and Family Screening
- Targeted genetic testing: Confirms the inheritance pattern (dominant, due to APCDD1, or recessive, due to LPAR6/LIPH).
- Genetic counseling: Families can learn the chance of passing the condition to a child: 50% for the dominant form, and 25% for the recessive form when both parents are carriers.
Cosmetic and Psychological Support
- Medical cosmetic options: Breathable mesh hair systems, hair-thickening fibers or scalp micropigmentation (SMP) can noticeably improve appearance in adulthood.
- Emotional support: School-age children with HHS benefit from psychological support to protect them from the emotional harm of feeling self-conscious about their looks.
